LMR Partners’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,093	Closed	-$421K	–	959
2024 Q1	$421K	Buy	+11,093	New	+$421K	﹤0.01%	384
2022 Q4	–	Sell	-769	Closed	-$10K	–	1254
2022 Q3	$10K	Hold	769	–	–	﹤0.01%	1176
2022 Q2	$10K	Buy	+769	New	+$10K	﹤0.01%	1250